Sign In
Buy ISPC
$2.75
+0 (+0%)
At Close: Jun 12, 2026
iSpecimen Reschedules Full Year 2023 Earnings Release and Conference Call
07:07pm, Tuesday, 12'th Mar 2024
The Company will now report results after the market closes on March 13, 2024 and reschedules conference call to Thursday, March 14, 2024 at 8:30am Eastern The Company will now report results after th
iSpecimen to Report Full Year 2023 Financial Results on March 13, 2024
04:30pm, Tuesday, 05'th Mar 2024
LEXINGTON, Mass., March 05, 2024 (GLOBE NEWSWIRE) -- iSpecimen Inc. (Nasdaq: ISPC) (“iSpecimen” or the “Company”), an online global marketplace that connects scientists requiring biospecimen
iSpecimen and TriMetis Life Sciences Announce Strategic Partnership to Help Transform Tissue-Based Research
07:30am, Tuesday, 23'rd Jan 2024
Partnership Aims to Optimize Quality Control and Assurance Through Digital AI Histopathology Services Partnership Aims to Optimize Quality Control and Assurance Through Digital AI Histopathology Servi
iSpecimen to Participate in Maxim Group Healthcare IT Virtual Conference, January 24 & 25, 2024
08:11am, Thursday, 18'th Jan 2024
LEXINGTON, Mass., Jan. 18, 2024 (GLOBE NEWSWIRE) -- iSpecimen Inc. (Nasdaq: ISPC) (“iSpecimen” or the “Company”), an online global marketplace that connects scientists requiring biospecimens f
iSpecimen Strengthens Global Oncology Biospecimen Offering
07:30am, Thursday, 07'th Dec 2023
Adds New Suppliers and Expands Existing Relationships to Provide Researchers Increased Access to Highly-Sought-After Biospecimens to Advance Oncology Research Adds New Suppliers and Expands Existing R
iSpecimen Inc. (ISPC) Q3 2023 Earnings Call Transcript
04:39pm, Friday, 03'rd Nov 2023
iSpecimen Inc. (NASDAQ:ISPC ) Q3 2023 Earnings Conference Call November 2, 2023 8:30 AM ET Company Participants Phil Carlson - Investor Relations, KCSA Strategic Communications Tracy Curley - Chief Ex
iSpecimen Reports Third Quarter 2023 Financial and Operating Results
07:30am, Thursday, 02'nd Nov 2023
Sequential Quarterly Revenue Growth of 75% Driven by Enhanced Operational Efficiencies of iSpecimen Marketplace and Rollout of New Business Initiatives Sequential Quarterly Revenue Growth of 75% Driv
iSpecimen Expands Proprietary Provider Network to Help Advance Infectious Disease Research
07:30am, Thursday, 26'th Oct 2023
New Providers Facilitate Access to Diverse and Hard-to-Reach Populations and Support Complex Custom Projects New Providers Facilitate Access to Diverse and Hard-to-Reach Populations and Support Comple
iSpecimen Preannounces Third Quarter 2023 Revenue Increase of 60-70% Sequentially
07:30am, Monday, 23'rd Oct 2023
Management to Host Third Quarter 2023 Conference Call on Thursday, November 2, 2023 Management to Host Third Quarter 2023 Conference Call on Thursday, November 2, 2023
iSpecimen Launches Next-Day Quote Service for Medical Researchers and Biospecimen Providers
07:30am, Thursday, 28'th Sep 2023
Accurate Pricing Delivered Within 24 Hours to Enhance the Customer Journey and Accelerate Medical Research Accurate Pricing Delivered Within 24 Hours to Enhance the Customer Journey and Accelerate Med
iSpecimen Expands Provider Network to Enhance Support for Women's Health Research
07:30am, Wednesday, 13'th Sep 2023
Additional Providers Increase Biospecimen Access for Researchers Focused on Cervical, Uterine and Breast Cancers, as well as Reproductive Health, Cardiovascular Disease, Autoimmune Disorders and STIs
iSpecimen Announces Organizational Changes to Enhance Operational Efficiencies and Drive Profitability
04:05pm, Wednesday, 06'th Sep 2023
Company to Focus on Core Revenue Drivers, New Revenue Growth Opportunities from Recently Launched Sequencing Procurement Program and Expense Reductions Company to Focus on Core Revenue Drivers, New Re
iSpecimen Launches New Virtual Cancer Sequencing Procurement Program
07:30am, Wednesday, 30'th Aug 2023
Program to Provide Cancer Researchers with Direct Access to Highly Sought Donor Tumor Tissue Samples Virtual Inventory Comprised of Formalin-Fixed, Paraffin-Embedded (FFPE) Samples Screened for Mutati
iSpecimen Enhances Proprietary Marketplace Platform to Streamline Biospecimen Matchmaking for Researchers and Providers
07:30am, Wednesday, 16'th Aug 2023
New Capabilities Enable Platform to Efficiently Collect and Store Most Up-to-Date Data from Providers and Facilitate Automated, Instant Matchmaking for Researcher Requests New Capabilities Enable Plat
